SKI Market

A+| A| A-|

Indian Indices

Sensex

77,470.11 -238.41
( -0.31%)

Global Indices

Nasdaq

51,860.73 -306.69
(-0.59%)

Dow Jones

7,464.20 -14.49
(-0.19%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,580.59 55.83
(0.53%)

Forex

USD-INR

96.42 0.06
(0.07%)

EUR-INR

110.27 -0.10
(-0.09%)

GBP-INR

129.65 -0.46
(-0.35%)

JPY-INR

0.59 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Veer Global Infraconstruction Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

543241

INE244W01010

22.2388019

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

167.07

222.53

EPS(TTM)

Face Value()

Div & Yield %

0.82

Back

radiant global projects ltd

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

Feb 09,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

77,470.11 -238.41 ( -0.31%)

51,860.73 -306.69 (-0.59%)

7,464.20 -14.49 (-0.19%)

66,064.76 1,923.64 (3.00%)

10,580.59 55.83 (0.53%)

96.42 0.06 (0.07%)

110.27 -0.10 (-0.09%)

129.65 -0.46 (-0.35%)

0.59 0.00 (-0.05%)